Products
OUR PRODUCTS

CATALOG NO | PRODUCT NAME | CAS NO |
CBL/001 | alpha,alpha’-Dibromo-p-xylene | 623-24-5 |
CBL/002 | 1-(4-methylphenyl)propan-2-one | 2096-86-8 |
CBL/003 | 2,6-Dimethoxybenzaldehyde | 3392-97-0 |
CBL/004 | 2,6-dihydroxybenzaldehyde | 387-46-2 |
CBL/005 | 2-Chloro-4-picoline | 3678-62-4 |
CBL/006 | (2-Nitrophenyl)(phenyl)methanone | 2243-79-0 |
CBL/007 | 2-Aminobenzophenone | 2835-77-0 |
CBL/008 | 5-Bromo-1(H)-Indazole | 53857-57-1 |
CBL/009 | 2-Benzylaniline | 28059-64-5 |
CBL/010 | 5-benzoyl-benzimidazoline-2-thione | 92685-57-9 |
CBL/011 | 5-benzoyl-1H-benzo[d]imidazole-2-sulfonic acid | 929960-88-3 |
CBL/012 | (2-amino-3H-benzimidazol-5-yl)-phenylmethanone | 52329-60-9 |
CBL/013 | 2-Bromo-6-methoxynaphthalene | 5111-65-9 |
CBL/014 | 6-(3-chloropropyl)benzo[d]thiazol-2(3H)-one | 135792-95-9 |
CBL/015 | 3-Methyl-2-nitrobenzoic acid | 5437-38-7 |
CBL/016 | 2-Acetyl-6-methoxynaphthalene | 3900-45-6 |
CBL/017 | 1-(6-Methoxy-2-Naphthyl)Ethanol | 77301-42-9 |
CBL/018 | 6-methoxy-2-ethylnaphthalene | 21388-17-0 |
CBL/019 | Methyl p-tolyl sulfoxide | 934-72-5 |
CBL/020 | 4-Bromo-2-nitrophenol | 7693-52-9 |
CBL/021 | 2-Amino-4-bromophenol | 40925-68-6 |
CBL/022 | 5-Bromobenzooxazole | 132244-31-6 |
CBL/023 | 2-Amino-4-fluorobenzoic acid | 446-32-2 |
CBL/024 | 2-methyldibenzo[b,d]thiophene 5-oxide | 77096-69-6 |
CBL/025 | 1-(benzenesulfonyl)-4-methylbenzene | 640-57-3 |
CBL/026 | 4-(Methylthio)toluene | 623-13-2 |
CBL/027 | Quinoline-2-carbonitrile | 1436-43-7 |
CBL/028 | 1-(2-Methoxyethyl)-4-nitrobenzene | 69628-98-4 |
CBL/029 | 4-(2-Methoxyethyl)phenol | 56718-71-9 |
CBL/030 | ethyl 2-iodoacetate | 623-48-3 |
CBL/031 | 3-amino-4-hydroxybenzoic acid | 1571-72-8 |
Contact
Chembricks Laboratories Pvt.Ltd.,
H.No.7-102/26, Zaheera Nagar,
Habsiguda,, Hyderabad – 500079
Telangana. India
Phone : +91 90147 59900
Email : info@chembrickslabs.com

Chembricks is a leading research-driven pharmaceutical company founded in the year 2019, is a leading service provider in the areas of Chemical Development of Heterocyclic compounds, Natural Products and API Intermediates is poised to become a leading drug company in India.